Wal-Fex Fexofenadine Hydrochloride tablets, 180mg/antihistamine, 24HR, packaged as a) 5 count b...

FDA Drug Recall #D-0352-2022 — Class II — July 27, 2021

Recall Summary

Recall Number D-0352-2022
Classification Class II — Moderate risk
Date Initiated July 27, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Perrigo Company PLC
Location Allegan, MI
Product Type Drugs
Quantity 14,160 containers

Product Description

Wal-Fex Fexofenadine Hydrochloride tablets, 180mg/antihistamine, 24HR, packaged as a) 5 count bottle, NDC 0363-0600-13,UPC 3 11917 12267 0, b)30 count bottle, NDC 0363-0600-39 UPC 3 11917 16172 3 c) 90 count bottle, NDC 0363-0600-75 UPC 3 11917 12271 7 ; Distributed by Walgreen Co. 200 Wilmot Rd Deerfield IL 60015, Made in the Czech Republic,

Reason for Recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot # a)0JE2406, Exp 02/28/2022 b) 0FR0459, Exp 02/28/2022. c) 0KR0465, Exp 04/30/2022

Other Recalls from Perrigo Company PLC

Recall # Classification Product Date
D-0623-2022 Class II No Drip Nasal Spray, Oxymetazoline HCl 0.05% Na... Oct 26, 2021
D-0601-2022 Class II Acetaminophen Child Bubble Gum Flavored Oral Su... Oct 26, 2021
D-0580-2022 Class II Children's Pain & Fever Bubblegum Flavored Ace... Oct 26, 2021
D-0607-2022 Class II Severe Congestion Nasal Spray, No Drip Plus Men... Oct 26, 2021
D-0624-2022 Class II Maximum Strength No Drip Nasal Spray, Oxymetazo... Oct 26, 2021

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.